Trying to Rise from the Dead | GenomeWeb

While Decode Genetics was able to find many links between genes and disease, "what it didn't find, however, was a business model that made sense," says this Newsweek article, and Decode went bankrupt in November. The company, however, is trying to rise from the ashes with an investment from Saga. The new CEO, Earl Collier is trying to turn Decode into a consulting company that would analyze researchers' sequencing data and "[give] it back in a nicely packaged way."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.